Hepatocellular carcinoma (HCC) is probably the most commonly diagnosed cancer of the liver and the fourth leading explanation for cancer-related mortality worldwide, with China accounting for over half of the worldwide annual cases and deaths. Hepatectomy is the usual curative-intent treatment option for appropriately chosen patients with localized HCC. Nonetheless, the high postoperative reoccurrence rate […]